Approvals, plants and specialist knowledge create entry barriers — and valuation premiums for established chemicals and pharma companies.
Chemicals and pharma companies sell entry barriers: approvals, validated processes and plants a buyer cannot replicate at short notice. Valuations of established specialists are correspondingly robust.
In the process, documentation and compliance count — REACH, GMP, environmental permits. A prepared data room with complete dossiers shortens due diligence and protects the price.
We approach strategics and specialised investors in parallel and keep competition alive until exclusivity.
Find out — without obligation — what your company is worth and what a process could look like for you.
Machinery & plant engineering, manufacturing, suppliers — IP, order backlog and production depth drive value.
SaaS, IT services, managed services — recurring revenue drives the highest multiples in the Mittelstand.
B2B services, maintenance, facility, consulting — recurring revenue in an actively consolidating market.
